Tech Company Financing Transactions
Arcturus Therapeutics Funding Round
Private investors participated in a $5.9 million capital raise for Arcturus Therapeutics. This venture round was announced on 10/28/2015.
Transaction Overview
Company Name
Announced On
10/28/2015
Transaction Type
Debt
Amount
$5,924,599
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10628 Science Ctr. Dr. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Arcturus Therapeutics is focused on developing novel RNA therapeutics for the treatment of various diseases aiming on Rare Diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Payne
Chief Financial Officer
Andrew Sassine
Chief Operating Officer
Padmanabh Chivukula
Browse more venture capital transactions:
Prev: 10/28/2015: 3nder venture capital transaction
Next: 10/28/2015: Commerce Signals venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs